Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The year-on-year decline in operating profit and below was mainly due to the impact of temporary income recognized in the second quarter of the previous fiscal year. Selling, general and administrative expenses increased because of M&A activities and upfront investments in personnel and new businesses in the previous fiscal year. As a result of reassessing the recoverability of upfront payments made to Hippocratic AI, Inc., the Company recognized extraordinary losses, including a loss on contract termination.
None (the note on the going concern assumption states, “There are no applicable matters.”)
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | ¥13,678 million (YoY +30.0%) |
| Operating profit | ¥395 million (YoY -65.2%) |
| Ordinary income | ¥361 million (YoY -63.2%) |
| Profit attributable to owners of the parent | ¥489 million (YoY -40.6%) |
| Net income per share | ¥13.67 |
| Equity ratio | End of the current fiscal period 31.2 / End of previous period 31.5 |
| Total assets | ¥67,466 million |
| Net assets | ¥22,315 million |
| Cash flows from operating activities | ¥551,037 thousand |
| Cash flows from investing activities | ¥92,104 thousand |
| Cash flows from financing activities | ¥1,242,724 thousand |
| Cash and cash equivalents at end of period | ¥10,937,151 thousand |
| Full-year earnings forecast | Net Sales ¥33,035 million (YoY +33.6%) / Operating profit ¥2,864 million (YoY +21.1%) / Ordinary income ¥2,648 million (YoY +23.9%) / Net income ¥1,658 million (YoY -40.3%) |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Segment revenue | Comprehensive Medical Management Support Business ¥5,042,924 thousand (YoY +64.8%), Senior-Related Businesses ¥4,426,977 thousand (YoY +19.9%), Highly Controlled Medical Devices Business ¥3,832,163 thousand (YoY +7.9%), Other businesses ¥376,377 thousand (YoY +71.5%) |
| Segment profit | Comprehensive Medical Management Support Business ¥456,961 thousand (YoY -64.8%), Senior-Related Businesses ¥311,876 thousand (YoY +66.4%), Highly Controlled Medical Devices Business ¥240,063 thousand (YoY -13.0%), Other businesses ¥117,520 thousand (YoY +186.2%) |
| Depreciation and amortization | ¥485,442 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥4,228 thousand, Gain on sale of investment securities ¥20,068 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥29,672 thousand, Extraordinary Losses ¥32,482 thousand, Contract cancellation losses ¥65,790 thousand, Other ¥935 thousand |
| Disclosure regarding the going concern assumption | None (the note on the going concern assumption states, “There are no applicable matters.”) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社リリフル / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Held (対象者：Not disclosed) |
| Issued Shares at Period-End | 37,982,900 Shares |
| Treasury Shares at Period-End | 2,193,800 Shares |
| Factors Behind Changes in Business Performance | The year-on-year decline in operating profit and below was mainly due to the impact of temporary income recognized in the second quarter of the previous fiscal year. Selling, general and administrative expenses increased because of M&A activities and upfront investments in personnel and new businesses in the previous fiscal year. As a result of reassessing the recoverability of upfront payments made to Hippocratic AI, Inc., the Company recognized extraordinary losses, including a loss on contract termination. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The decline in operating profit and below was mainly due to the impact of temporary income recognized in the second quarter of the previous fiscal year. Selling, general and administrative expenses also increased as a result of the M&A activities conducted in the previous fiscal year and upfront investments in personnel and new businesses. In addition, the recoverability of upfront payments made to Hippocratic AI, Inc. was reassessed, resulting in the recognition of an extraordinary loss.